| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/28/2009 | WO2009066967A2 Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same |
| 05/28/2009 | WO2009066807A1 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it |
| 05/28/2009 | WO2009066806A1 Purification method of human erythropoietin |
| 05/28/2009 | WO2009066757A1 Protein-responsive translation control system utilizing rna-protein interaction motif |
| 05/28/2009 | WO2009066454A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/28/2009 | WO2009066320A2 Gcsf fusion protein systems suitable for high expression of peptides |
| 05/28/2009 | WO2009066180A2 Method for the separation of cells |
| 05/28/2009 | WO2009066175A1 Peptide analogues and conjugates thereof |
| 05/28/2009 | WO2009066174A1 Improved cytokine design |
| 05/28/2009 | WO2009066010A1 Method for detecting nt-probnp or the nt-probnp/probnp ratio |
| 05/28/2009 | WO2009065934A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same |
| 05/28/2009 | WO2009065912A2 Plants having increased yield-related traits and a method for making the same |
| 05/28/2009 | WO2009065546A1 Poxviral oncolytic vectors |
| 05/28/2009 | WO2009065415A1 Polypeptides comprising an ice-binding activity |
| 05/28/2009 | WO2009065296A1 Gene engineering immunorepressive polypeptides and their preparing methods and uses |
| 05/28/2009 | WO2009043858A3 Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease |
| 05/28/2009 | WO2009035804A3 Gene silencing of the brother of the regulator of imprinted sites (boris) |
| 05/28/2009 | WO2009034436A3 'hematopoietic cells that express tmcc-1' |
| 05/28/2009 | WO2009028880A3 Biomarker composition for detecting diabetic retinopathy and diagnostic kit therefor |
| 05/28/2009 | WO2009027335A3 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants |
| 05/28/2009 | WO2009009139A3 Rna ligase polypeptides and methods of selection and use thereof |
| 05/28/2009 | WO2008146164A3 Streptococcus pneumoniae pilus antigens |
| 05/28/2009 | WO2008145129A3 Influenza vaccines |
| 05/28/2009 | WO2008097541A4 Variants derived from actriib and uses therefor |
| 05/28/2009 | WO2008073620A3 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| 05/28/2009 | WO2007008732A3 Compositions and methods for suppressing axonal growth inhibition |
| 05/28/2009 | WO2006037052A3 Modulating mxa expression |
| 05/28/2009 | WO2006023248A3 Processes for producing and crystallizing g-protein coupled receptors |
| 05/28/2009 | WO2005077099A3 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g) |
| 05/28/2009 | US20090138987 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
| 05/28/2009 | US20090138984 Genes involved in tolerance to environmental stress |
| 05/28/2009 | US20090138977 Pancreatic cancer targets and uses thereof |
| 05/28/2009 | US20090138204 Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy |
| 05/28/2009 | US20090137818 Crystal structure of human coronavirus 229E main proteinase and uses for developing SARS inhibitors |
| 05/28/2009 | US20090137788 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 05/28/2009 | US20090137785 Rab9 protein crystal structures and methods for identifying rab9 modulators |
| 05/28/2009 | US20090137783 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 05/28/2009 | US20090137779 Peptide inhibitors of thrombin as potent anticoagulants |
| 05/28/2009 | US20090137778 A HIV peptide consisting of 23 to 50 amino acid residues; trans-activator |
| 05/28/2009 | US20090137763 Glucosamine nucleotide sugars |
| 05/28/2009 | US20090137762 Method of forming a polymerized hemoglobin solution from stabilized hemoglobin |
| 05/28/2009 | US20090137680 Novel non-selective cation channel in neuronal cells and method for treating brain swelling |
| 05/28/2009 | US20090137518 Therapeutic Antiangiogenic Endostatin Compositions |
| 05/28/2009 | US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof |
| 05/28/2009 | US20090137501 Resistance Genes |
| 05/28/2009 | US20090137484 Neuronal Network-Interacting Peptide |
| 05/28/2009 | US20090137482 Biologically active peptide and agent containing the same |
| 05/28/2009 | US20090137481 Antimicrobial polypeptides |
| 05/28/2009 | US20090137476 Apo-2 ligand variants and uses thereof |
| 05/28/2009 | US20090137472 Chimeric mhc protein and oligomer thereof |
| 05/28/2009 | US20090137471 Ngf variants |
| 05/28/2009 | US20090137468 Cytotoxic factors for modulating cell death |
| 05/28/2009 | US20090137465 Novel use |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090137462 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 05/28/2009 | US20090137456 Glucagon analogs exhibiting physiological solubility and stability |
| 05/28/2009 | US20090137454 Insulin Derivatives |
| 05/28/2009 | US20090137427 Method for generating hypermutable organisms |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau |
| 05/28/2009 | US20090137050 Artificial protein, method for absolute quantification of proteins and uses thereof |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 05/28/2009 | US20090137004 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 05/28/2009 | US20090137001 Process for preparing recombinant human thrombin with culture cell |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136996 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 05/28/2009 | US20090136984 Method and means for enrichment removal and detection of listeria |
| 05/28/2009 | US20090136975 transient receptor potential (TRP) family of ion channels; recombinant vectors, host cells; high throughput screening, drug screening |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 05/28/2009 | US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses |
| 05/28/2009 | US20090136941 Methods, kits and compositions pertaining to linear beacons |
| 05/28/2009 | US20090136920 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) |
| 05/28/2009 | US20090136914 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
| 05/28/2009 | US20090136649 Protein having ice nucleation activity |
| 05/28/2009 | US20090136567 Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia Coli |
| 05/28/2009 | US20090136552 Growth factors nsg28, nsg30, and nsg32 |
| 05/28/2009 | US20090136548 Multiple antigenic peptides immunogenic against streptococcus pneumonia |
| 05/28/2009 | US20090136542 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein |
| 05/28/2009 | US20090136536 Recombinant Subunit Vaccine |
| 05/28/2009 | US20090136530 Influenza Hemagglutinin and Neuraminidase Variants |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
| 05/28/2009 | US20090136522 Multivalent Immunogen |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target |
| 05/28/2009 | US20090136498 Method for Manufacturing Recombinant Polyclonal Proteins |
| 05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |
| 05/28/2009 | US20090136454 Anti-inflammatory activity from lactic acid bacteria |
| 05/28/2009 | US20090136444 molecule and chimeric molecules thereof |
| 05/28/2009 | US20090136421 PAI-2 conjugates for the treatment and imaging of cancer |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | DE102007056836A1 Peptid-Antibiotikum aus Hydra sowie hierfür codierendes Gen Peptide antibiotic from Hydra and this encoding gene |
| 05/28/2009 | CA2706882A1 Bone morphogenic protein binding peptide |
| 05/28/2009 | CA2706550A1 Polypeptides comprising an ice-binding activity |